Spots Global Cancer Trial Database for neutropenia
Every month we try and update this database with for neutropenia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors | NCT03798665 | Neutropenia | Pegfilgrastim（P... | 18 Years - | Affiliated Hospital of North Sichuan Medical College | |
| A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome | NCT03087370 | WHIM Syndrome | No intervention | - | X4 Pharmaceuticals | |
| Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer | NCT00002866 | Breast Cancer Neutropenia | filgrastim docetaxel epirubicin hydr... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer | NCT00113789 | Ovarian Cancer | PI Discretion | 18 Years - | Amgen | |
| Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia | NCT02536599 | Febrile Neutrop... | - 18 Years | Assiut University | ||
| Daptomycin in Treating Neutropenia and Fever in Patients With Cancer | NCT00335478 | Fever Sweating Hot Flashes Infection Neutropenia Unspecified Adu... | Daptomycin | 18 Years - 99 Years | OHSU Knight Cancer Institute | |
| Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma | NCT00794261 | Lymphoma Myeloma | Injection of Pe... Injection of Fi... | 18 Years - | Centre Leon Berard | |
| Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients | NCT01060462 | Hematological M... Neutropenia Fever | Pts. w/ neutrop... | 18 Years - | Janssen Korea, Ltd., Korea | |
| A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer. | NCT02135887 | Stage III Color... Neutropenia | MB-6 Placebo | 20 Years - 80 Years | Microbio Co Ltd | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) | NCT00686543 | Fungal Infectio... Acute Myelogeno... Neutropenia | Posaconazole | 18 Years - | Merck Sharp & Dohme LLC | |
| Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer | NCT04187898 | Neutropenia Breast Cancer | Eflapegrastim Eflapegrastim Eflapegrastim Eflapegrastim Docetaxel Cyclophosphamid... | 18 Years - 55 Years | Spectrum Pharmaceuticals, Inc | |
| Shwachman Diamond Syndrome Registry and Study | NCT06056908 | Shwachman-Diamo... Shwachman-Diamo... | - | Boston Children's Hospital | ||
| Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy | NCT00048971 | Colorectal Canc... Diarrhea Neutropenia | mutation analys... polymorphic mic... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00004192 | Lymphoma Neutropenia | filgrastim pegfilgrastim cisplatin cytarabine etoposide methylprednisol... | 18 Years - 120 Years | University of Nebraska | |
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia | NCT03019939 | Acute Myeloid L... Myelodysplastic... Neutropenia | Isavuconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients | NCT01523431 | Metastatic Colo... | Irinotecan Inje... 5-fluorouracil Leucovorin | 18 Years - | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation | NCT01519648 | Invasive Fungal... | 1 Year - 95 Years | National Hematological Society, Russia | ||
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections | NCT00002277 | Mycoses HIV Infections | Fluconazole Amphotericin B | 13 Years - | NIH AIDS Clinical Trials Information Service | |
| Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome | NCT00002800 | Leukemia Myelodysplastic... Neutropenia | filgrastim lintuzumab cytarabine etoposide idarubicin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer | NCT00113789 | Ovarian Cancer | PI Discretion | 18 Years - | Amgen | |
| Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia | NCT00004215 | Anemia Leukemia Neutropenia Thrombocytopeni... | filgrastim leridistim cytarabine daunorubicin hy... | 55 Years - | Memorial Sloan Kettering Cancer Center | |
| Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer | NCT01680575 | Epithelial Ovar... | 20 Years - 80 Years | Asan Medical Center | ||
| SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia | NCT02324231 | Cancer Pediatrics Fever Neutropenia Fever in Neutro... | 39.0°C temperat... 38.5°C temperat... | 1 Year - 18 Years | Swiss Pediatric Oncology Group | |
| Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO | NCT02149329 | Febrile Neutrop... Hematological M... | Discontinuation... | 18 Years - | Amsterdam UMC, location VUmc | |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer | NCT02725606 | Chemotherapy-in... | Pegylated Recom... GW003 | 18 Years - 70 Years | Jiangsu T-Mab Biopharma Co.,Ltd | |
| A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy | NCT00555516 | Breast Cancer Chemotherapy Neutropenia | EW02 | 20 Years - 70 Years | Tri-Service General Hospital | |
| Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia | NCT00002693 | Leukemia Neutropenia | filgrastim carboplatin topotecan hydro... | 18 Years - | Mayo Clinic | |
| Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies | NCT04773327 | Gynecologic Mal... | Mecapegfilgrast... | 18 Years - 70 Years | Fudan University | |
| Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers | NCT02700360 | Chemotherapy-In... | high-fat diet EC-18 | 19 Years - 45 Years | Enzychem Lifesciences Corporation | |
| Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) | NCT04618081 | Lymphoma Nonhod... | 18 Years - | Celgene | ||
| Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia | NCT03019939 | Acute Myeloid L... Myelodysplastic... Neutropenia | Isavuconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer | NCT00030758 | Breast Cancer Neutropenia | filgrastim pegfilgrastim | 18 Years - | National Cancer Institute (NCI) | |
| Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy | NCT00035620 | Sarcoma Neutropenia | pegfilgrastim filgrastim | - 21 Years | Amgen | |
| Cologne Cohort of Neutropenic Patients (CoCoNut) | NCT01821456 | Hematological M... Cancer Chemotherapy Neutropenia Immunosuppressi... | Antiinfectives | 1 Year - | University Hospital of Cologne | |
| Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies | NCT00533078 | Colitis Mucositis AML | omegaven | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients | NCT03251768 | Chemotherapy-in... | rHSA-GCSF 2.4mg GCSF | 18 Years - 65 Years | Tianjin SinoBiotech Ltd. | |
| Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO | NCT02149329 | Febrile Neutrop... Hematological M... | Discontinuation... | 18 Years - | Amsterdam UMC, location VUmc | |
| Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma | NCT00115193 | Non-Hodgkin's L... | pegfilgrastim pegfilgrastim | 18 Years - | Amgen | |
| Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO | NCT02149329 | Febrile Neutrop... Hematological M... | Discontinuation... | 18 Years - | Amsterdam UMC, location VUmc | |
| The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies | NCT01669005 | Neutropenia | - | Centre Hospitalier Universitaire Vaudois | ||
| Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers | NCT02532712 | Chemotherapy-In... | EC-18 Placebo | 19 Years - 45 Years | Enzychem Lifesciences Corporation | |
| Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children | NCT00129688 | Neutropenia Cancer Fever | cloxacillin and... | 1 Year - 14 Years | Khon Kaen University | |
| AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients | NCT05793073 | Neutropenia | 18 Years - | Centre Hospitalier Universitaire de Nice | ||
| Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer | NCT00352300 | Fallopian Tube ... Infectious Diso... Neutropenia Ovarian Carcino... Primary Periton... Stage III Ovari... Stage IV Ovaria... | Adjuvant Therap... Carboplatin Paclitaxel Pegfilgrastim | 18 Years - | GOG Foundation | |
| A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement | NCT02190721 | Neutropenia | tbo-filgrastim | 1 Month - 16 Years | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | NCT02527746 | Neutropenia Breast Cancer | F-627 EC regimen | 18 Years - 75 Years | EVIVE Biotechnology | |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | NCT01431326 | Adenovirus Anesthesia Anxiety Anxiolysis Autism Autistic Disord... Bacterial Menin... Bacterial Septi... Benzodiazepine Bipolar Disorde... Bone and Joint ... Central Nervous... Convulsions Cytomegalovirus... Early-onset Sch... Epilepsy General Anesthe... Gynecologic Inf... Herpes Simplex ... Infantile Heman... Infection Inflammation Inflammatory Co... Intra-abdominal... Lower Respirato... Migraines Pain Pneumonia Schizophrenia Sedation Seizures Skeletal Muscle... Skin and Skin-s... Treatment-resis... Urinary Tract I... Withdrawal Sepsis Gram-negative I... Bradycardia Cardiac Arrest Cardiac Arrhyth... Staphylococcal ... Nosocomial Pneu... Neuromuscular B... Methicillin Res... Endocarditis Neutropenia Headache Fibrinolytic Bl... Pulmonary Arter... CMV Retinitis Hypertension Chronic Kidney ... Hyperaldosteron... Hypokalemia Heart Failure Hemophilia Heavy Menstrual... Insomnia | The POPS study ... | - 21 Years | Duke University | |
| Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | NCT00002658 | Leukemia Neutropenia | filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | 15 Years - | National Cancer Institute (NCI) | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00077311 | Anemia Drug/Agent Toxi... Lung Cancer Neutropenia | darbepoetin alf... pegfilgrastim cisplatin docetaxel BNP7787 | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer | NCT00031980 | Anemia Leukemia Neutropenia Thrombocytopeni... | cyclosporine | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00004192 | Lymphoma Neutropenia | filgrastim pegfilgrastim cisplatin cytarabine etoposide methylprednisol... | 18 Years - 120 Years | University of Nebraska | |
| Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies | NCT04710212 | Hematologic Mal... Leukemia, Acute Neutropenia Bloodstream Inf... | No intervention... | 18 Years - | Duke University | |
| Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | NCT02872103 | Breast Cancer Neutropenia | F-627 Placebo | 18 Years - 74 Years | EVIVE Biotechnology | |
| Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients | NCT02104830 | Chemotherapy-in... | Empegfilrastim ... Filgrastim Placebo №1 Placebo №2 Empegfilrastim ... | 18 Years - 70 Years | Biocad | |
| Fever and Neutropenia in Pediatric Oncology Patients | NCT03768869 | Fever Neutropenia | Low Risk: Oupat... Low Risk: Inpat... High Risk: Inpa... | 0 Years - 21 Years | University of Colorado, Denver | |
| Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients | NCT05221593 | Neutropenia | Lithium Carbona... | - | Al-Azhar University | |
| Profiling Neutrophil Counts in Patients on Chemotherapy | NCT02806557 | Neoplasms Neutropenia Febrile Neutrop... | Home finger-pri... | 18 Years - | University of Leeds | |
| Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer | NCT00031980 | Anemia Leukemia Neutropenia Thrombocytopeni... | cyclosporine | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia | NCT02544230 | Neutropenia Fever Bacterial Infec... Fungal Infectio... Fever of Unknow... Hematological N... Sepsis | 18 Years - | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | ||
| A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients | NCT03343145 | Breast Cancer | Leucostim 5µg/k... Neupogen 5µg/kg... | 18 Years - 70 Years | Dong-A ST Co., Ltd. | |
| A Study of Ceftobiprole in Patients With Fever and Neutropenia. | NCT00529282 | Fever Neutropenia Gram-positive B... Pseudomonas Inf... | Ceftobiprole Me... Cefepime with o... | 18 Years - | Basilea Pharmaceutica | |
| Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy | NCT01571518 | Neutropenia | late leukostim early leukostim | 20 Years - 70 Years | Sunchonhang University | |
| Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies | NCT04773327 | Gynecologic Mal... | Mecapegfilgrast... | 18 Years - 70 Years | Fudan University | |
| Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E | NCT01931592 | Cancer | ESBL eradicatio... Placebo ESBL er... | 18 Years - | University of Cologne | |
| Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients | NCT06075888 | Immunodepressed... | Metagenomic dia... | 18 Years - | Poitiers University Hospital | |
| Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment | NCT00608738 | Chemotherapeuti... Infection Malnutrition Musculoskeletal... Neutropenia Radiation Toxic... Thrombocytopeni... Unspecified Adu... | informational i... medical chart r... questionnaire a... assessment of t... management of t... | 21 Years - | Northwestern University | |
| Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer | NCT01724866 | Neutropenia | SPI-2012 Pegfilgrastim Docetaxel Cyclophosphamid... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Screening for Hematology Branch Protocols | NCT00001620 | Hematologic Dis... Donors Healthy Volunte... | 2 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients | NCT05221593 | Neutropenia | Lithium Carbona... | - | Al-Azhar University | |
| SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide | NCT02953340 | Neutropenia Breast Cancer | SPI-2012 Pegfilgrastim Docetaxel Cyclophosphamid... | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | NCT00497809 | Breast Cancer Neutropenia | AVI-014 versus ... | 18 Years - | AviGenics | |
| A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer | NCT00277160 | Neutropenia Breast Cancer Lung Cancer Non-Hodgkin's L... Ovarian Cancer | Neulasta (pegfi... | 65 Years - | Amgen | |
| A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer. | NCT02135887 | Stage III Color... Neutropenia | MB-6 Placebo | 20 Years - 80 Years | Microbio Co Ltd | |
| Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy | NCT00296049 | Infection Neutropenia Unspecified Adu... Unspecified Chi... | daptomycin vancomycin | - 120 Years | Wake Forest University Health Sciences | |
| Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting | NCT00107081 | Fever Neutropenia Cancer | ciprofloxacin a... Outpatient mana... i.v. antibiotic... inpatient manag... | 1 Year - 18 Years | Swiss Pediatric Oncology Group | |
| Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies | NCT05672420 | Hematologic Neo... Neutropenia Anemia Thrombocytopeni... Infections Bleeding | umbilical cord ... | 18 Years - 75 Years | Wuhan Union Hospital, China | |
| Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim | NCT01516736 | Chemotherapy-in... Breast Cancer | LA-EP2006 Neulasta® | 18 Years - | Sandoz | |
| A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer | NCT00001338 | Breast Neoplasm... Fever Hematologic Dis... Neutropenia Sepsis | FLAC chemothera... | - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
